Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Intended Use: For Laboratory Research Use Only Key Characteristics of Retatrutide (12 mg) Triple Receptor Targeting: Designed for experimental activation of GLP-1, GIP, and glucagon receptors
After losing a significant amount of weight, your body may require fewer calories to maintain its current state
Some patients experience therapeutic benefitsincluding weight loss and improved blood glucosewithout significant nausea or other side effects, particularly when dose escalation follows the recommended gradual schedule
Products should also be reviewed with the accompanying photographs to verify their legitimacy. Both the FDA and Novo Nordisk are testing the seized products and do not have information about their identity, quality or safety
